Surveillance imaging: minimal evidence and forgotten harms
- PMID: 40519223
- PMCID: PMC12164362
- DOI: 10.1136/bmjonc-2024-000724
Surveillance imaging: minimal evidence and forgotten harms
Keywords: Medical oncology.
Conflict of interest statement
HV-A reports travel support from AstraZeneca and Asofarma, and consulting fees from Asofarma outside of the submitted work. BW reports consulting fees from AstraZeneca, Novartis and Gilead, outside of the submitted work, and unrelated grants from BMS.
References
-
- Harrison HS, Khan B, Farsi B, et al. A Systematic Review Comparing Surveillance Recommendations for the Detection of Recurrence Following Surgery across 16 Common Cancer Types. BMJ Oncology. 2024;4 doi: 10.1136/bmjonc-2024-000627. - DOI
Publication types
LinkOut - more resources
Full Text Sources